{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:55Z","timestamp":1793900515487,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial pneumonia of unknown aetiology with a mean survival rate of less than 3\u00a0years. No previous studies have been performed on the role of co-infection (viral and bacterial infection) in the pathogenesis and progression of IPF. In this study, we investigated the role of viral\/bacterial infection and coinfection and their possible association with pathogenesis and progression of IPF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We investigated the prevalence and impact of bacterial and viral coinfection in IPF patients (n\u2009=\u200967) in the context of pulmonary function (FVC, FEV\n                      <jats:sub>1<\/jats:sub>\n                      and DL\n                      <jats:sub>CO<\/jats:sub>\n                      ), disease status and mortality risk. Using principal component analysis (PCA), we also investigated the relationship between distribution of bacterial and viral co-infection in the IPF cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 67 samples, 17.9% samples were positive for viral infection, 10.4% samples were positive for bacterial infection and 59.7% samples were positive coinfection. We demonstrated that IPF patients who were co-infected had a significantly increased risk of mortality compared (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031) with IPF patients who were non-infected [Hazard ratio: 8.12; 95% CI 1.3\u201326.9].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this study, we report for the first time that IPF patients who were coinfected with bacterial and viral infection have significantly decreased FVC and DL\n                      <jats:sub>CO<\/jats:sub>\n                      (% predicted). Besides, the results demonstrated the increased AE-IPF, increased incidence of death and risk of mortality in infected\/coinfected patients compared to non-infected IPF patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-022-01853-y","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T07:02:38Z","timestamp":1644562958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Bacterial and viral coinfection in idiopathic pulmonary fibrosis patients: the prevalence and possible role in disease progression"],"prefix":"10.1186","volume":"22","author":[{"given":"Mohsen","family":"Moghoofei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Mostafaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Kondori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"1853_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/qjmed\/hcs067","volume":"105","author":"SC Donnelly","year":"2012","unstructured":"Donnelly SC. Review series-inflammation and fibrosis. Introduction. QJM. 2012;105:503.","journal-title":"QJM"},{"key":"1853_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier J-F, Flaherty KR, Lasky JA. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"1853_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12016-010-8211-5","volume":"40","author":"AT Borchers","year":"2011","unstructured":"Borchers AT, Chang C, Keen CL, Gershwin ME. Idiopathic pulmonary fibrosis\u2014an epidemiological and pathological review. Clin Rev Allergy Immunol. 2011;40:117\u201334.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1853_CR4","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1099\/jmm.0.000628","volume":"66","author":"H Keyvani","year":"2017","unstructured":"Keyvani H, Moghoofei M, Bokharaei-Salim F, Mostafaei S, Mousavi S-AJ, Monavari SH, Esghaei M. Prevalence of respiratory viruses in Iranian patients with idiopathic pulmonary fibrosis. J Med Microbiol. 2017;66:1602\u20136.","journal-title":"J Med Microbiol"},{"issue":"Suppl 2","key":"1853_CR5","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1513\/AnnalsATS.201502-088AW","volume":"12","author":"BB Moore","year":"2015","unstructured":"Moore BB, Moore TA. Viruses in idiopathic pulmonary fibrosis. Etiology and exacerbation. Ann Am Thorac Soc. 2015;12(Suppl 2):S186-192.","journal-title":"Ann Am Thorac Soc"},{"key":"1853_CR6","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1183\/09031936.97.10092040","volume":"10","author":"M Yonemaru","year":"1997","unstructured":"Yonemaru M, Kasuga I, Kusumoto H, Kunisawa A, Kiyokawa H, Kuwabara S, Ichinose Y, Toyama K. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J. 1997;10:2040\u20135.","journal-title":"Eur Respir J"},{"key":"1853_CR7","doi-asserted-by":"publisher","first-page":"e27800","DOI":"10.1371\/journal.pone.0027800","volume":"6","author":"I Lasithiotaki","year":"2011","unstructured":"Lasithiotaki I, Antoniou KM, Vlahava VM, Karagiannis K, Spandidos DA, Siafakas NM, Sourvinos G. Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases. PLoS ONE. 2011;6:e27800.","journal-title":"PLoS ONE"},{"key":"1853_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1164\/ajrccm\/146.1.266","volume":"146","author":"T Ueda","year":"1992","unstructured":"Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T, Watanabe J, Miyamoto T, Ito K. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis. 1992;146:266\u20138.","journal-title":"Am Rev Respir Dis"},{"key":"1853_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2169\/internalmedicine.49.3890","volume":"49","author":"Y Umeda","year":"2010","unstructured":"Umeda Y, Morikawa M, Anzai M, Sumida Y, Kadowaki M, Ameshima S, Ishizaki T. Acute exacerbation of idiopathic pulmonary fibrosis after pandemic influenza A (H1N1) vaccination. Intern Med. 2010;49:2333\u20136.","journal-title":"Intern Med"},{"key":"1853_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636\u201343.","journal-title":"Am J Respir Crit Care Med"},{"key":"1853_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1164\/rccm.201403-0541OC","volume":"190","author":"PL Molyneaux","year":"2014","unstructured":"Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, Murphy E, Johnston SL, Schwartz DA, Wells AU, et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014;190:906\u201313.","journal-title":"Am J Respir Crit Care Med"},{"key":"1853_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s15010-019-01350-1","volume":"48","author":"M Moghoofei","year":"2020","unstructured":"Moghoofei M, Jamalkandi SA, Moein M, Salimian J, Ahmadi A. Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Infection. 2020;48:19\u201335.","journal-title":"Infection"},{"key":"1853_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12931-017-0511-3","volume":"18","author":"PL Molyneaux","year":"2017","unstructured":"Molyneaux PL, Cox MJ, Wells AU, Kim HC, Ji W, Cookson WO, Moffatt MF, Kim DS, Maher TM. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis. Respir Res. 2017;18:29.","journal-title":"Respir Res"},{"key":"1853_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1128\/cdli.2.4.448-453.1995","volume":"2","author":"S Tyler","year":"1995","unstructured":"Tyler S, Strathdee C, Rozee K, Johnson W. Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S\u201323S rRNA internal transcribed spacers. Clin Diagn Lab Immunol. 1995;2:448\u201353.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1853_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1099\/jmm.0.015198-0","volume":"59","author":"JF Turton","year":"2010","unstructured":"Turton JF, Perry C, Elgohari S, Hampton CV. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol. 2010;59:541\u20137.","journal-title":"J Med Microbiol"},{"key":"1853_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1755-1536-1-2","volume":"1","author":"KM Vannella","year":"2008","unstructured":"Vannella KM, Moore BB. Viruses as co-factors for the initiation or exacerbation of lung fibrosis. Fibrogenesis Tissue Repair. 2008;1:2.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"1853_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1586\/ers.10.73","volume":"4","author":"PK Naik","year":"2010","unstructured":"Naik PK, Moore BB. Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med. 2010;4:759\u201371.","journal-title":"Expert Rev Respir Med"},{"key":"1853_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2213-2600(14)70088-8","volume":"2","author":"PL Molyneaux","year":"2014","unstructured":"Molyneaux PL, Maher TM. Respiratory microbiome in IPF: Cause, effect, or biomarker? Lancet Respir Med. 2014;2:511\u20133.","journal-title":"Lancet Respir Med"},{"key":"1853_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1183\/09059180.00000713","volume":"22","author":"PL Molyneaux","year":"2013","unstructured":"Molyneaux PL, Maher TM. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. Eur Respir Rev. 2013;22:376\u201381.","journal-title":"Eur Respir Rev"},{"key":"1853_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1172\/JCI30595","volume":"117","author":"A Meneghin","year":"2007","unstructured":"Meneghin A, Hogaboam CM. Infectious disease, the innate immune response, and fibrosis. J Clin Investig. 2007;117:530\u20138.","journal-title":"J Clin Investig"},{"key":"1853_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1164\/rccm.200211-1311OC","volume":"168","author":"HR Collard","year":"2003","unstructured":"Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:538\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"1853_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1164\/rccm.200210-1245OC","volume":"168","author":"PI Latsi","year":"2003","unstructured":"Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med. 2003;168:531\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1853_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/archinte.1953.00240230006002","volume":"92","author":"A Golden","year":"1953","unstructured":"Golden A, Bronk TT. Diffuse interstitial fibrosis of lungs; a form of diffuse interstitial angiosis and reticulosis of the lungs. AMA Arch Intern Med. 1953;92:106\u201314.","journal-title":"AMA Arch Intern Med"},{"key":"1853_CR24","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2147\/TCRM.S87789","volume":"11","author":"MA Hendaus","year":"2015","unstructured":"Hendaus MA, Jomha FA, Alhammadi AH. Virus-induced secondary bacterial infection: a concise review. Ther Clin Risk Manag. 2015;11:1265\u201371.","journal-title":"Ther Clin Risk Manag"},{"key":"1853_CR25","doi-asserted-by":"publisher","first-page":"e97470","DOI":"10.1172\/jci.insight.97470","volume":"3","author":"KM Robinson","year":"2018","unstructured":"Robinson KM, Ramanan K, Clay ME, McHugh KJ, Pilewski MJ, Nickolich KL, Corey C, Shiva S, Wang J, Muzumdar R, Alcorn JF. The inflammasome potentiates influenza\/Staphylococcus aureus superinfection in mice. JCI Insight. 2018;3:e97470.","journal-title":"JCI Insight"},{"key":"1853_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1164\/rccm.201304-0760OC","volume":"188","author":"DN O'Dwyer","year":"2013","unstructured":"O\u2019Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, Simpson AJ, Millar AB, McGrath EE, Whyte MK, et al. The toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2013;188:1442\u201350.","journal-title":"Am J Respir Crit Care Med"},{"key":"1853_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1517\/14728222.2014.988706","volume":"19","author":"DN O\u2019Dwyer","year":"2015","unstructured":"O\u2019Dwyer DN, Armstrong ME, Kooblall M, Donnelly SC. Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis. Expert Opin Ther Targets. 2015;19:507\u201314.","journal-title":"Expert Opin Ther Targets"},{"key":"1853_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nri3446","volume":"13","author":"LA O'Neill","year":"2013","unstructured":"O\u2019Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors\u2014redefining innate immunity. Nat Rev Immunol. 2013;13:453\u201360.","journal-title":"Nat Rev Immunol"},{"key":"1853_CR29","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413:732\u20138.","journal-title":"Nature"},{"key":"1853_CR30","doi-asserted-by":"publisher","first-page":"e00168","DOI":"10.1128\/mBio.00168-16","volume":"7","author":"L Spelmink","year":"2016","unstructured":"Spelmink L, Sender V, Hentrich K, Kuri T, Plant L, Henriques-Normark B. Toll-like receptor 3\/TRIF-dependent IL-12p70 secretion mediated by Streptococcus pneumoniae RNA and Its priming by influenza A virus coinfection in human dendritic cells. MBio. 2016;7:e00168-e116.","journal-title":"MBio"},{"key":"1853_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1074\/jbc.M411223200","volume":"280","author":"E Aksoy","year":"2005","unstructured":"Aksoy E, Zouain CS, Vanhoutte F, Fontaine J, Pavelka N, Thieblemont N, Willems F, Ricciardi-Castagnoli P, Goldman M, Capron M, et al. Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem. 2005;280:277\u201383.","journal-title":"J Biol Chem"},{"key":"1853_CR32","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1084\/jem.20081370","volume":"205","author":"KA Cavassani","year":"2008","unstructured":"Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, Hogaboam CM, Kunkel SL. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med. 2008;205:2609\u201321.","journal-title":"J Exp Med"},{"key":"1853_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1164\/rccm.201311-1956ED","volume":"188","author":"I Noth","year":"2013","unstructured":"Noth I, Kaminski N. Idiopathic pulmonary fibrosis: Time to get personal? Am J Respir Crit Care Med. 2013;188:1392\u20134.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-01853-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-01853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T11:57:02Z","timestamp":1674734222000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-01853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-01853-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-790046\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"10 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from Kermanshah University of Medical Sciences (IR.KUMS.REC.1397.764). We confirm that written informed consent to participate was obtained from all of the participants in our study. We acquired permissions and\/or licenses to access the clinical\/personal patient data used in our research from Kermanshah University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}